Target intelligence / Profile preview

Plasma membrane (PM) (PM)

Target
PM
Molecular classification
Other
01

Overview

The plasma membrane is a fundamental biological structure that serves as the semi-permeable boundary of the eukaryotic cell, composed primarily of a phospholipid bilayer interspersed with proteins and cholesterol (Alberts et al., 2002). It plays a critical role in maintaining cellular homeostasis by regulating the transport of ions and molecules, and it serves as the primary site for signal transduction through various receptors and ion channels (Lodish et al., 2000). While not typically classified as a single therapeutic target due to its immense complexity, the membrane's physical properties and lipid composition are modulated by several classes of drugs. For instance, certain anesthetics and antifungal agents like Amphotericin B interact with membrane components to cause pore formation or alter fluidity (StatPearls, 2023). Alterations in membrane composition are associated with numerous pathologies, including cancer and neurodegenerative diseases, where changes in fluidity or lipid raft organization can impact cell signaling (Maxfield & Tabas, 2005). In cancer, the membrane often exhibits altered lipid asymmetry and increased rigidity, which can contribute to drug resistance (Hendrich & Michalak, 2003). Consequently, while specific proteins within the membrane are the primary focus of drug discovery, the membrane itself remains a vital structural context for pharmacological intervention.

Other names
Eukaryotic cell membraneCytoplasmic membranePlasmalemmaCell membrane
02

Mechanism of action

Modulation of membrane fluidity, pore formation, and disruption of lipid-protein interactions (StatPearls, 2023; Alberts et al., 2002).

03

Biological functions

Signal transductionOther
04

Disease associations

CancerInfectionOther
05

Safety considerations

Non-specific cytotoxicityHemolysisDisruption of essential electrochemical gradients
06

Interacting drugs

Amphotericin B

3 more in the full profile.

07

Biomarkers

Phosphatidylserine exposureMembrane fluidityLipid raft composition

Beyond the preview

Go deeper on Plasma membrane (PM) (PM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasma membrane (PM) (PM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call